ACGN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ACGN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Total Premiums Earned only applies to insurance companies.
Vincent Milano | director, officer: President & CEO | C/O VIROPHARMA INC, 405 EAGLEVIEW BLVD, EXTON PA 19341 |
Maxine Gowen | director | |
Pillar Invest Corp | director, 10 percent owner | C/O PILLAR INVEST OFFSHORE SAL, STARCO CENTER, BLOC B FL3, OMAR DAOUK ST, BEIRUT M8 2020-3313 |
Atul Chopra | 10 percent owner | C/O ACERAGEN, INC., 15 TW ALEXANDER DRIVE, DURHAM NC 27709 |
John Clayton Taylor | director, officer: Chief Executive Officer | C/O ACERAGEN, INC., 15 TW ALEXANDER DRIVE, DURHAM NC 27709 |
Carl N Kraus | officer: Chief Medical Officer | C/O ACERAGEN, INC., 15 TW ALEXANDER DRIVE, DURHAM NC 27709 |
Andrew R Jordan | officer: Chief Strategy Officer | C/O GUILFORD PHARMACEUTICALS INC, 6611 TIBUTARY ST., BALTIMORE MD 21224 |
Daniel Salain | officer: Chief Operating Officer | C/O GRAYBUG VISION, INC., 275 SHORELINE DRIVE, SUITE 450, REDWOOD CITY CA 94065 |
Ronald J Wooten | director | |
Nq Pof V Gp, Ltd. | director, other: See Remarks | 4208 SIX FORKS ROAD, SUITE 920, RALEIGH NC 27609 |
Novaquest Co-investment Fund Xv, L.p. | director, other: See Remarks | 4208 SIX FORKS ROAD, SUITE 920, RALEIGH NC 27609 |
John J. Kirby | officer: V.P. of Finance, PFO & PAO | C/O IDERA PHARMACEUTICALS, INC., 505 EAGLEVIEW BLVD., SUITE 212, EXTON PA 19341 |
Michael R Dougherty | director | C/O ADOLOR CORP, 700 PENNSYLVANIA DR, EXTON PA 19341 |
Elizabeth Ann Tarka | officer: Chief Medical Officer | 111 WAVERLY CIRCLE, PHOENIXVILLE PA 19460 |
Bryant David Lim | officer: SVP & General Counsel | C/O IDERA PHARMACEUTICALS, INC., 505 EAGLEVIEW BLVD., SUITE 212, EXTON PA 19341 |
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.